These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3161636)

  • 61. Measles campaign: $11 million saved in New South Wales.
    Christopher PJ
    Med J Aust; 1989 Oct; 151(8):485-6. PubMed ID: 2593963
    [No Abstract]   [Full Text] [Related]  

  • 62. The estimation of the economic burden of measles in terms of direct and indirect costs per case.
    Svihrova V; Szilagyiova M; Waczulikova I; Novakova E; Hudeckova H
    Infect Dis (Lond); 2018 Apr; 50(4):324-327. PubMed ID: 29131686
    [No Abstract]   [Full Text] [Related]  

  • 63. The costs of preventing measles.
    Sloan D
    JAMA; 1992 Feb; 267(5):656. PubMed ID: 1731131
    [No Abstract]   [Full Text] [Related]  

  • 64. [Epidemiological analysis of measles occurence in the district of Olomouc in 1970--1976 (author's transl)].
    Janout V
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):84-91. PubMed ID: 149607
    [No Abstract]   [Full Text] [Related]  

  • 65. Measles immunization in Sydney.
    Christopher PJ
    Med J Aust; 1972 Aug; 2(8):414-5. PubMed ID: 5086299
    [No Abstract]   [Full Text] [Related]  

  • 66. Costs and benefits of measles vaccination in Finland.
    Ekblom M; Elo O; Laurinkari J; Niemelä P
    Scand J Soc Med; 1978; 6(3):111-5. PubMed ID: 103198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Measles control in Africa.
    Dabis F; Waldman RJ; Sow A; Jones TS; Madzou G
    Lancet; 1986 Jul; 2(8499):162-3. PubMed ID: 2873423
    [No Abstract]   [Full Text] [Related]  

  • 68. Costs associated with measles in healthcare personnel during the 2017-2018 epidemic in Greece: a real-world data cost-of-illness analysis.
    Maltezou HC; Dedoukou X; Pavi E; Theodoridou M; Athanasakis K
    J Hosp Infect; 2020 May; 105(1):91-94. PubMed ID: 31843560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Journal of Tropical Pediatrics and environmental child health. Editorial.
    Morley D
    J Trop Pediatr Environ Child Health; 1971 Jun; 17(2):45-6. PubMed ID: 5210159
    [No Abstract]   [Full Text] [Related]  

  • 70. [Ethical issues and preventive vaccination].
    Malvy D; Le Bras M
    Sante; 1999; 9(2):129-34. PubMed ID: 10377502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Consensus conference on measles.
    Can Commun Dis Rep; 1993 May; 19(10):72-9. PubMed ID: 8348101
    [No Abstract]   [Full Text] [Related]  

  • 72. [Economic effect of vaccination against measles in Czechoslovakia].
    Skovránková J
    Cesk Epidemiol Mikrobiol Imunol; 1985 Jun; 34(4):227-33. PubMed ID: 3161636
    [No Abstract]   [Full Text] [Related]  

  • 73. [Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].
    Hudecková H; Straka S; Avdicová M; Rusnáková S
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):31-5. PubMed ID: 11233671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evaluation of vaccination policies. The case of measles].
    Lafarge H; Levy E; Rey M
    Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Epidemiological study and cost evaluation of measles in Lyons hospitals over a 5-year period].
    Loras-Duclaux I; David L; Peyramond D; Floret D; Lachaux A; Hermier M
    Pediatrie; 1988; 43(5):451-4. PubMed ID: 3200658
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.